Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,437,332
-$867,476 QoQ
Shares Held
134,149
+0.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#206
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. AZN ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
134,149 | $25,437,332 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,437,332 | 134,149 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $26,304,808 | 133,378 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||